Submit Your Multidisciplinary Research to Diseases
Join researchers worldwide publishing breakthrough studies across clinical medicine, epidemiology, public health, and biomedical sciences
Complete your submission in just 15 minutes
Two Convenient Submission Methods
Choose the submission pathway that works best for your research workflow. Both methods provide secure, efficient manuscript handling with full tracking capabilities.
ManuscriptZone Portal
Our comprehensive manuscript management system designed for complete control and transparency throughout the peer review process.
- Real-time submission status tracking
- Auto-save functionality prevents data loss
- Direct communication with editors and reviewers
- Guided workflow with validation checks
- Secure document storage and version control
- Instant notifications on manuscript progress
Best for: Authors who want full visibility into the review process and prefer a structured submission experience.
Submit via ManuscriptZoneQuick Submission Form
A streamlined submission process for straightforward manuscripts that require minimal back-and-forth during preparation.
- Simple one-page submission form
- No account registration required
- Fast upload for ready manuscripts
- Ideal for single-author submissions
- Immediate confirmation email
- Transferred to ManuscriptZone automatically
Best for: Authors with complete, submission-ready manuscripts who prefer a simplified process.
Use Quick Submission FormManuscript Types We Publish
Diseases welcomes diverse research contributions across multiple disciplines. Our multidisciplinary scope encompasses clinical medicine, epidemiology, public health, infectious diseases, chronic disease management, and biomedical research. Each manuscript type undergoes rigorous peer review by experts in the relevant field.
Original Research Articles
Comprehensive studies presenting novel findings in disease mechanisms, clinical trials, epidemiological investigations, or therapeutic interventions.
Systematic Reviews & Meta-Analyses
Evidence synthesis studies following PRISMA guidelines, analyzing disease prevalence, treatment efficacy, or diagnostic accuracy across multiple studies.
Clinical Case Reports
Detailed documentation of rare diseases, unusual presentations, novel treatment approaches, or unexpected clinical outcomes with educational value.
Epidemiological Studies
Population-based research on disease distribution, risk factors, outbreak investigations, or public health interventions following STROBE guidelines.
Review Articles
Comprehensive overviews of current knowledge in specific disease areas, emerging therapies, or evolving diagnostic approaches.
Short Communications
Concise reports of preliminary findings, novel methodologies, or timely observations that warrant rapid dissemination to the research community.
Methodology Papers
Detailed descriptions of novel research techniques, diagnostic tools, statistical approaches, or experimental protocols applicable to disease research.
Perspectives & Commentaries
Expert opinions on controversial topics, emerging trends in disease research, or critical analysis of current practices in clinical or public health settings.
Pre-Submission Checklist
Ensure your manuscript meets all requirements before submission to expedite the review process. Complete manuscripts receive faster editorial screening and peer review assignment.
Manuscript File Ready
Word (.docx) or LaTeX format, double-spaced, with line numbers. Include title page with all author information and affiliations.
Figures & Tables Prepared
High-resolution figures (300 DPI minimum) in TIFF, EPS, or PNG format. Tables in editable format with clear captions.
Ethics Approval Obtained
IRB/Ethics committee approval for human studies. IACUC approval for animal research. Include approval numbers and dates.
Author Agreements Secured
All co-authors have reviewed and approved the manuscript. Corresponding author designated with valid email address.
Competing Interests Declared
Complete disclosure of financial relationships, conflicts of interest, or potential biases related to the research.
Reporting Guidelines Followed
CONSORT for trials, STROBE for observational studies, PRISMA for reviews, CARE for case reports, or ARRIVE for animal studies.
Peer Review Timeline
We maintain transparent, predictable timelines throughout the review process. Our editorial team works diligently to provide timely decisions while ensuring rigorous peer review quality.
Submission & Initial Screening
3 daysEditorial office reviews your manuscript for completeness, formatting compliance, and scope alignment. Plagiarism check performed using iThenticate. Manuscripts with >30% similarity are returned for revision.
Editor Assignment
2 daysAn editor with expertise in your research area is assigned. The editor evaluates scientific merit, novelty, and suitability for the journal before proceeding to peer review.
Peer Review Process
21 daysMinimum two expert reviewers evaluate your manuscript for scientific rigor, methodology, data quality, and contribution to the field. Reviewers provide detailed feedback and recommendations.
Editorial Decision
2 daysBased on reviewer reports, the editor makes a decision: Accept, Minor Revisions, Major Revisions, or Reject. You receive detailed feedback and specific revision requests if applicable.
Revision & Re-review
14 daysSubmit your revised manuscript with a detailed response to reviewers. The editor and reviewers evaluate your revisions to ensure all concerns have been adequately addressed.
Acceptance & Production
10 daysUpon acceptance, your manuscript enters production for copyediting, typesetting, and final formatting. You'll receive proofs for approval before publication.
Online Publication
ImmediateYour article is published online with a DOI, immediately accessible worldwide. Indexed in major academic databases and Google Scholar for maximum visibility.
Total Timeline: Submission to Publication
Average: 60 days from initial submission to online publication for manuscripts accepted after first review.
Fast-track option available for time-sensitive research such as outbreak investigations, urgent public health findings, or breakthrough clinical discoveries.
Why Researchers Choose Diseases
Rigorous Peer Review
Expert reviewers from leading institutions worldwide ensure scientific quality and methodological rigor across all disciplines.
Fast Decisions
Average 21 days to first decision. We respect your time and provide prompt, constructive feedback to advance your research.
Global Indexing
Your research reaches worldwide audiences through major academic databases and Google Scholar indexing.
Open Access Impact
Immediate, unrestricted access maximizes citations and real-world impact. Your work reaches clinicians, policymakers, and researchers globally.
Ethical Standards
Committed to COPE publication ethics, transparent peer review, and rigorous standards. We handle misconduct allegations seriously and fairly.
APC Waivers Available
Financial support for researchers from low-income countries and unfunded studies. We never let finances prevent quality research publication.
Discipline-Specific Submission Guidelines
Clinical Research & Trials
Clinical trials must be registered in a WHO-approved registry (ClinicalTrials.gov, ISRCTN, etc.) before patient enrollment. Include registration number in abstract. Follow CONSORT reporting guidelines for randomized trials, SPIRIT for protocols, and TREND for non-randomized evaluations. Provide ethics approval documentation and patient consent procedures.
Epidemiological Studies
Population-based studies should follow STROBE guidelines for cohort, case-control, and cross-sectional designs. Clearly describe sampling methodology, response rates, and potential selection bias. For outbreak investigations, include case definitions, attack rates, and epidemic curves. Provide ethics approval for studies involving human subjects or identifiable data.
Laboratory & Biomedical Research
Describe experimental methods in sufficient detail for replication. Include reagent sources, catalog numbers, and lot numbers where applicable. For animal studies, follow ARRIVE guidelines and provide IACUC approval. Report statistical methods, sample size calculations, and data analysis approaches. Make raw data available in supplementary files or public repositories.
Public Health Interventions
Intervention studies should follow RE-AIM or other appropriate frameworks. Describe implementation context, fidelity measures, and sustainability considerations. Include stakeholder engagement processes and community partnership details. Report both quantitative outcomes and qualitative implementation insights.
Systematic Reviews & Meta-Analyses
Register your review protocol in PROSPERO or similar registry before data extraction. Follow PRISMA reporting guidelines and include completed checklist. Describe search strategy for all databases, screening process, quality assessment tools, and statistical methods for meta-analysis. Provide GRADE evidence quality ratings where applicable.
Manuscript Preparation Support
We understand that manuscript preparation can be challenging, especially for early-career researchers or those for whom English is not a first language. Our editorial team is committed to supporting you throughout the submission process.
Resources Available to Authors
Author Guidelines: Comprehensive formatting instructions, reference style examples, and figure preparation specifications.
Reporting Checklists: CONSORT, STROBE, PRISMA, CARE, ARRIVE, and other discipline-specific reporting guidelines.
Statistical Review: Optional statistical consultation available for complex analyses or novel methodologies.
Language Editing: Recommendations for professional editing services if needed to improve manuscript clarity.
Cover Letter Templates: Examples of effective cover letters that highlight research significance and novelty.
Ready to Submit Your Research?
Join researchers worldwide who trust Diseases for rigorous peer review and rapid publication of multidisciplinary disease research.
Start Your SubmissionNeed assistance? Our editorial team is here to help: [email protected]
